Close Price Date


Close Price

Delisted from BME Growth / Listed on Spanish Stock Exchange

"ATRYS Health specializes in innovative medical diagnostic imaging.and personalized cancer diagnosis and treatments in advanced single-dose radiation therapy company. Our commitment to R & D puts us at the forefront of individualized medicine ."


Company Profile

Atrys Health (BME:ATRY), founded in 2015, is a global medical services provider with more than 2,200 professionals and presence in 8 countries. A pioneer in the fields of telemedicine and state-of-the-art radiotherapy, it has a solid track record of organic and inorganic growth with the integration of 14 companies since 2018.

Atrys focuses its activity around three business units: prevention, diagnosis and oncology. Through these three areas, provides a 360º service, covering everything from prevention to cancer treatment, including precision diagnosis and the use of telemedicine. Thus, the company performs diagnostic tests, analyses using telemedicine tests on radiology, cardiology, ophthalmology and dermatology and provides medical oncology services carrying out chemotherapy, immunotherapy and advanced radiotherapy treatments.

Inside Information

Other Relevant Information


Relevant Facts until 10/05/2020

Significant participations

Financial Reports

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at or visit the website

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties for a fee, it is required a prior and express permission from BME Market Data. Please contact us at